Back

Association of ticagrelor vs clopidogrel with net adverse clinical events in NSTEMI patients with mild thrombocytopenia

31 August 2024 (13:00 - 13:40)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk and interventions: comparisons, disparities, and clinical trials Big Data Analysis ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Kang-Yin Chen

2nd Hospital of Tianjin Medical University, Tianjin (China)

5 More presentations in this session

Presentation thumbnail
GenePHIT phase 2 study design: a double blind, placebo-controlled trial to assess efficacy, safety, and tolerability of AB-1002 gene therapy in adults with heart failure
Doctor L. Roberts (Reading, GB)
Abstract Slides Video
Presentation thumbnail
Education level and the incidence of heart failure, acute myocardial infarction, and stroke in patients with atrial fibrillation
Doctor A. Sztaniszlav (Orebro, SE)
Abstract Slides Video
Presentation thumbnail
Factors associated with major adverse cardiovascular events among Arabs and Jews in Israel: a population-based cohort study
Associate Professor O. Kalter-Leibovici (Ramat Gan, IL)
Abstract Slides Video
Presentation thumbnail
Assessing aortic morphology post aortic valve replacement using unsupervised hierarchical clustering and statistical shape modelling
Mr Y. Aljassam (Bristol, GB)
Abstract Slides Video
Presentation thumbnail
Sub-Saharan Africa's contribution to clinical trials in international acute coronary syndromes and heart failure guidelines
Doctor J. Hudson (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular risk and interventions: comparisons, disparities, and clinical trials

The Event

Event poster

ESC Congress 2024

31 August 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Association of ticagrelor vs clopidogrel with net adverse clinical events in STEMI patients with mild thrombocytopenia
thumbnail
Congress Presentation
Association of ticagrelor vs clopidogrel with net adverse clinical events in patients with mild thrombocytopenia undergoing PCI
thumbnail
Congress Presentation
The effect of ticagrelor on patients with acute myocardial infarction and malnutrition

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources